Discover why DexCom (DXCM) could rebound in 2025. Explore buyback plans, growth potential, and investment insights in the ...

Brown Advisory, an investment management company, released its “Brown Advisory Mid-Cap Growth Strategy” third-quarter 2025 ...

DexCom Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy in 2026. On December 2, Morgan Stanley upgraded DexCom to ...

DexCom, Inc. ( NASDAQ:DXCM ) shareholders should be happy to see the share price up 12% in the last month. But ...

Dexcom ’s board has confirmed that President and Chief Operating Officer Jacob S. Leach will assume the roles of President, Chief Executive Officer and director effective January 1, 2026, following ...

DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by a huge potential in the continuous glucose ...

Fintel reports that on December 17, 2025, Mizuho maintained coverage of DexCom (NasdaqGS:DXCM) with a Outperform recommendation. Analyst Price Forecast Suggests 33.91% Upside As of December 6, 2025, ...

Shares of DexCom Inc. DXCM shed 2.87% to $66.96 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 1.07% to 6,827.41 and Dow Jones ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

Senseonics earns a buy with Eversense 365 driving growth, Q3 revenue up 90% YoY, gross margin expansion, and Ascensia ...

In a report released on December 16, William Plovanic from Canaccord Genuity maintained a Buy rating on Dexcom, with a price target of $99.00. The company’s shares closed yesterday at $66.37.

As of December 6, 2025, the average one-year price target for DexCom is $88.06/share. The forecasts range from a low of $68.68 to a high of $117.60. The average price target represents an increase of ...